Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
UBS
Fuji
Chinese Patent Office
Dow
Moodys
Queensland Health
Argus Health
Novartis
Healthtrust

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203200

« Back to Dashboard

NDA 203200 describes IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE, which is a drug marketed by Perrigo R And D and is included in one NDA. It is available from ten suppliers. Additional details are available on the IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE profile page.

The generic ingredient in IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE is ibuprofen; phenylephrine hydrochloride. There are sixty-four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ibuprofen; phenylephrine hydrochloride profile page.
Summary for 203200
Tradename:IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Applicant:Perrigo R And D
Ingredient:ibuprofen; phenylephrine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 203200
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE ibuprofen; phenylephrine hydrochloride TABLET;ORAL 203200 ANDA Walgreen Company 0363-0158 0363-0158-46 10 BLISTER PACK in 1 CARTON (0363-0158-46) > 1 TABLET, FILM COATED in 1 BLISTER PACK
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE ibuprofen; phenylephrine hydrochloride TABLET;ORAL 203200 ANDA Rugby Laboratories 0536-1044 0536-1044-34 20 BLISTER PACK in 1 CARTON (0536-1044-34) > 1 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG;10MG
Approval Date:Jul 3, 2014TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
McKinsey
US Department of Justice
Argus Health
Baxter
Teva
McKesson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot